Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Bone scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri¹, Cumali Aktolun, Richard P Baum

¹Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy. mednuc@istitutotumori.mi.it

European Journal of Nuclear Medicine and Molecular Imaging

|March 3, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same author

Antitumor efficacy and safety of locoregional [<sup>177</sup>Lu]Lu-RM26 radionuclide therapy in glioblastoma.

European journal of nuclear medicine and molecular imaging·2026

Same author

Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using <sup>177</sup>Lu-, <sup>90</sup>Y-, and <sup>225</sup>Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same author

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

Current status of FAP therapy in solid tumors.

Seminars in nuclear medicine·2025

Same author

Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study.

Theranostics·2025